PDF(Pubmed)
Abstract：
BACKGROUND Congenital heart diseases (CHDs) are the most common form of birth defects, affecting the structure and function of neonatal hearts. Pulmonary valve stenosis (PVS) and ventricular septal defects (VSD) are 2 of the more prevalent forms, both of which can lead to significant morbidity if left untreated. The emergence of transcatheter techniques has revolutionized the therapeutic landscape, presenting minimally invasive yet effective alternatives to open-heart surgery and significantly reducing associated patient morbidity and recovery time. CASE REPORT The presented case details the management of a 19-year-old man with complex CHDs, highlighting the nuanced decision-making process that led to a transcatheter approach. The patient\'s clinical presentation, marked by symptoms reflective of significant cardiac compromise, demanded a tailored approach that utilized the latest advancements in non-surgical intervention. The successful closure of the VSD with an Amplatzer device and the resolution of PVS via balloon valvuloplasty were achieved without complications, showcasing the potential of these techniques in managing similar cases. The post-intervention period was marked by a noteworthy recovery, confirming the procedural efficacy and enhancing the patient\'s quality of life. CONCLUSIONS The favorable outcome of this case highlights the pivotal role of transcatheter interventions in treating complex CHDs and suggests a shift towards less invasive approaches in cardiac care. This case contributes valuable insights to the existing body of evidence, reinforcing the potential of transcatheter techniques to become the preferred treatment modality. With promising immediate and short-term results, these techniques highlight the need for continued research into their long-term efficacy and application across diverse patient demographics.
摘要：
背景技术先天性心脏病(CHDs)是出生缺陷的最常见形式,影响新生儿心脏的结构和功能。肺动脉瓣狭窄（PVS）和室间隔缺损（VSD）是两种更常见的形式，如果不及时治疗，两者都可能导致显著的发病率。经导管技术的出现彻底改变了治疗领域，提供微创但有效的心脏直视手术替代方案，并显着减少相关患者的发病率和恢复时间。案例报告该案例详细介绍了一名患有复杂CHD的19岁男子的管理，强调导致经导管方法的细微差别决策过程。病人的临床表现，以反映显著心脏受损的症状为标志，要求一种量身定制的方法，利用非手术干预的最新进展。使用Amplatzer装置成功闭合VSD，并通过球囊瓣膜成形术解决PVS，无并发症。展示这些技术在管理类似案件中的潜力。干预后的时期出现了显著的复苏,确认手术疗效并提高患者的生活质量。结论该病例的有利结果突出了经导管介入治疗在治疗复杂CHD中的关键作用，并表明心脏护理转向侵入性较小的方法。这个案例为现有的证据提供了宝贵的见解，加强经导管技术成为首选治疗方式的潜力。有了有希望的即时和短期结果，这些技术凸显了需要继续研究其长期疗效和在不同患者人口统计学中的应用.
